Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer
Dimitrios P. Bogdanos, Athanasios Gkoutzourelas, Vasileios Papadopoulos, Christos Liaskos, Eleni Patrikiou, Christina Tsigalou, Athanasios Saratziotis, Jiannis Hajiioannou, Thomas Scheper, Wolfgang Meyer, Lazaros I. Sakkas, Christos N. Papandreou
Topics & Concepts
Ovarian cancerEpitopeMedicineAntibodyImmunoassayImmunologyClinical significanceOncologyCancerInternal medicineSystemic Lupus Erythematosus ResearchT-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies Research